Suzhou Xinrui Medical researches and manufactures polymer valves for heart valve disease treatment.
Established in 2021, Suzhou Xinrui Medical is based in Suzhou, China. It researches, develops, and manufactures polymer valves for heart valve disease, with products designed for hemodynamic performance and fatigue resistance. The company raised at least CNY 10 million in angel funding in April 2022 and an undisclosed pre-Series A round in March 2023 led by HM Capital, with Northern Light Venture Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Suzhou Xinrui Medical Technology Co., Ltd.? This is my company